Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Mass Balance Recovery, Absorption, Metabolism and Excretion of [14C]-BLU-5937
Mass Balance Recovery, Absorption, Metabolism and Excretion of [14C]-BLU-5937

NCT05244759

CompletedPhase 1

Sponsor: Bellus Health Inc. - a GSK company

Conditions: Healthy

Interventions: [14C]-BLU-5937

Countries: United Kingdom

This is a single-centre, open-label, non-randomised, single-period, single-dose study in healthy male subjects designed to assess the mass balance recovery, PK, metabolite profile and metabolite identification of \[14C\]-BLU-5937.

Eligibility overview

Sex: MALE

Age: 30 Years to 65 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Healthy males

Exclusion Criteria:

* History of clinically significant cardiovascular, renal, hepatic, chronic respiratory or gastrointestinal disease, neurological or psychiatric disorder,as judged by the investigator
Locations (1)
  • Nottingham, Ruddington, United Kingdom